M(1) muscarinic acetylcholine receptors (mAChRs) are abundant in postsynaptic nerve terminals of all forebrain regions and have been implicated in the cognitive decline associated with Alzheimer's disease and other CNS pathologies. Consequently, major efforts have been spent in the development of subtype-selective positron emission tomography (PET) tracers for mAChRs resulting in the development of several (11)C-labeled probes. However, protocols for the preparation of (18)F-labeled mAChR-ligands have not been published so far. Here, we describe a straightforward procedure for the preparation of an (18)F-labeled M(1) mAChR agonist and its corresponding pinacol boronate radiolabeling precursor and the non-radioactive reference compound. The target compounds were prepared from commercially available aryl fluorides and Boc protected 4-aminopiperidine using a convergent reaction protocol. The radiolabeling precursor was prepared by a modification of the Miyaura reaction and labeled via the alcohol-enhanced Cu-mediated radiofluorination. The developed procedure afforded the radiotracer in a non-decay-corrected radiochemical yield of 17 ± 3% (n = 3) and in excellent radiochemical purity (>99%) on a preparative scale. Taken together, we developed a straightforward protocol for the preparation of an (18)F-labeled M(1) mAChR agonist that is amenable for automation and thus provides an important step towards the routine production of a (18)F-labeled M(1) selective PET tracer for experimental and diagnostic applications.
Preparation of a First (18)F-Labeled Agonist for M(1) Muscarinic Acetylcholine Receptors.
阅读:4
作者:Zlatopolskiy Boris D, Neumaier Felix, Rüngeler Till, Drewes Birte, Kolks Niklas, Neumaier Bernd
| 期刊: | Molecules | 影响因子: | 4.600 |
| 时间: | 2020 | 起止号: | 2020 Jun 23; 25(12):2880 |
| doi: | 10.3390/molecules25122880 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
